Please login to the form below

Not currently logged in
Email:
Password:

NOR-SWITCH

This page shows the latest NOR-SWITCH news and features for those working in and with pharma, biotech and healthcare.

Standing out in a crowd

Standing out in a crowd

explained. Switching. Once products reached the market Celltrion observed further challenges when it came to persuading physicians to switch patients from originator biologics to their biosimilar equivalents. ... This is despite work to study the effects

Latest news

  • Facing the new wave of biosimilars Facing the new wave of biosimilars

    One trial, the NOR-SWITCH study, has made a significant contribution to the evidence base for switching. ... Some policy makers have interpreted NOR-SWITCH results as confirmation of switching’s safety and efficacy.

  • Pfizer’s Remicade biosimilar receives Crohn's trial boost Pfizer’s Remicade biosimilar receives Crohn's trial boost

    In addition to existing data from the registration studies, real-world experience and the NOR-SWITCH trial, this data adds to the body of evidence supporting use of CT-P13 across ... That issue has already been studied to some extent in the NOR-SWITCH

  • NOR-SWITCH - the final piece in the biosimilar puzzle? NOR-SWITCH - the final piece in the biosimilar puzzle?

    that policymakers do not misinterpret or exaggerate the findings of the NOR-SWITCH trial. ... NOR-SWITCH is designed to evaluate the effects of a switch from the original biologic to a biosimilar.

  • Study finds no problems switching from Remicade to biosimilar Study finds no problems switching from Remicade to biosimilar

    The comparative trial - called NOR-SWITCH - was presented at the 2016 UEG Week in Vienna, Austria and showed that swapping from Remicade to a biosimilar version made by Celltrion posed no ... The data shows that safety and efficacy are maintained

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mednet Group

Communique Small consultancy of the year 2020. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics